Lotense® “Amlodipine besylate 5mg capsules” has been successfully launched in the Lebanese market, in May 2008. Lotense® belongs to Plain Calcium Antagonist’s category, which has a total market size of over $8.9 million. Launching plan included mailing campaign, which began by teasing mail followed by awareness mail targeting both pharmacists and physicians. More activities are yet to come to position Lotense® at the top amongst its category.